Contact Us
Trusted by 300+ Biopharma Companies

A Full-Service Global Specialty CRO Purpose-Built for Small and Mid-Size Biopharma

Our A-Team of former regulators, leading scientists, and senior clinical experts delivers an integrated approach spanning clinical pharmacology, regulatory strategy, quantitative sciences, and global trial operations to help you tackle complex science.

Connect With Us
End-to-End Capabilities

Comprehensive Drug Development Solutions

From preclinical development through marketing approval, our teams bring together the strategy, science, and execution to help you reach critical milestones with confidence.

Regulatory and Drug Development Consulting

  • Guidance from Former Regulatory Agency Experts
  • Regulatory Pathway Strategy & Planning
  • Strategic Preclinical & CMC Planning
  • Clinical Development Strategy
  • Regulatory Meetings & Submission Support
Learn More

Clinical Development Operations

  • Strategic Study Design & Planning
  • Specialized Early-Phase Clinical Development
  • Accelerated Study Start-Up & Site Activation
  • Predictable Patient Recruitment & Retention
  • Integrated Delivery: Early Development Through Registration
  • Comprehensive Clinical Safety and Pharmacovigilance
Learn More

Clinical Pharmacology, Modeling & Simulation

  • Translational Strategies
  • Modeling & Simulation for Dose Selection and Optimization
  • Clinical Pharmacology Study Design & Execution
  • PK, PD & Exposure-Response Analysis
  • Quantitative Support for Regulatory Interactions and Submissions
Learn More

Allucent Experience at a Glance

Therapeutic Expertise

Our ACE teams bring focused expertise across core therapeutic areas, combining specialized therapeutic insight with integrated development expertise to support smarter study design and more confident development decisions.

Allucent's Oncology ACE supports biopharma companies advancing therapies across solid tumors and hematologic malignancies.

From biomarker-driven patient selection and adaptive oncology trial designs to competitive enrollment in narrowly defined populations and accelerated regulatory pathways, our oncology experts help advance programs from early development through pivotal trials, regulatory submission, and approval.

Learn More

Specialized Expertise in Rare Diseases and Cell & Gene Therapies

Our scientific, operational, and regulatory experts support sponsors developing cell and gene therapies and treatments for rare and ultra-rare diseases. We help address complex study designs, evolving regulatory pathways, and specialized trial requirements to advance these programs.

Rare Diseases

Supporting New Possibilities for Rare Diseases

Deep scientific and therapeutic expertise to support the development of innovative treatments for rare and ultra-rare conditions.

Learn More
Cell & Gene Therapy

Helping Advance Transformative Cell & Gene Therapies

Integrated clinical, regulatory, and operational solutions to help bring innovative cell and gene therapies to patients.

Learn More
Technology-Accelerated Delivery
Lucent AI

AI Purpose-Built for Your Clinical Development

Allucent leverages AI to address real clinical development challenges for small and mid-size biopharma companies, not simply automate tasks. LucentAI™, our purpose-built AI platform, is embedded into the way we deliver clinical development solutions to help sponsors make better decisions and accelerate the development of new therapies.

Guided by our scientific, regulatory, and operational experts, LucentAI™ incorporates agentic and generative AI to drive efficiencies and orchestrate complex workflows. The result is trusted intelligence and AI-accelerated, meaningful impact from strategy and study start-up through execution and submission.

Why Allucent

Purpose-built For small and mid-size biopharma.

Nimble

Responsive teams and streamlined decision-making enable faster decisions, greater flexibility, and the agility to adapt as your program evolves.

A-Team

Senior experts remain actively engaged throughout your program, bringing experienced judgment and practical insight as your program progresses.

Partnership

Our teams become deeply invested in your program, working alongside you with a shared commitment to its success.

Insights & Updates

Recommended reads

Expert Conversation

How ctDNA Is Transforming MRD Monitoring in Hematologic Malignancies

Liquid biopsy technologies, particularly circulating tumor DNA, or ctDNA, are changing how clinicians monitor hematologic malignancies. In this Fierce Biotech…

Read more

Blog

Use of New Approach Methodologies in Drug Development: Perspectives on FDA’s Recent Draft Guidance

New approach methodologies (NAMs) offer alternative ways to evaluate drug safety and biological effects while helping reduce reliance on animal…

Read more

Infographic

AI Enabled Pharmacovigilance Infographic 

Pharmacovigilance teams face unprecedented data pressure from surging safety data volumes, expanding multi-channel sources, and increasingly complex clinical programs. To…

Read more
View All Resources
Industry Recognition

Recognized for our expertise and collaborative approach

Industry awards and finalist honors highlight the expertise, partnership, and clinical development support we bring to sponsors and their programs.

Get in touch

Let's talk about your program

Tell us a bit about what you're working on and our team will be in touch to discuss how Allucent can support your next milestone.

Sponsor Inquiry

North American Headquarters

2000 Centregreen Way, Suite 300,
Cary, North Carolina 27513

United Kingdom Headquarters

1st Floor, One Station Square,
Bracknell, Berkshire RG12 1QB
United Kingdom

European Headquarters

Stationsplein Noord-Oost 438,
1117 CL Schiphol,
The Netherlands

Frequently Asked Questions

Allucent is a global, full-service clinical research organization (CRO) that supports biopharma companies from early development through clinical trials to product registration. Its integrated services span regulatory and drug development consulting, clinical pharmacology, quantitative sciences, clinical development operations, and safety and pharmacovigilance. These services are tailored to each sponsor’s unique development needs.
At Allucent, being a specialty CRO means focusing on four therapeutic areas through our Allucent Centers of Expertise (ACEs): oncology and hematology, neuroscience, immunology and inflammation, and infectious diseases and vaccines. This focus helps our teams anticipate disease-specific challenges and apply their knowledge of patient populations, endpoints, and treatment landscapes to shape development strategies, design studies, and execute clinical trials.
Allucent specializes in four therapeutic areas through its Allucent Centers of Expertise (ACEs): oncology & hematology, neuroscience, immunology & inflammation, and infectious diseases & vaccines. These four ACE teams apply disease-specific scientific, regulatory, and operational expertise to develop study designs, regulatory strategies, and patient recruitment plans tailored to the specific requirements of the indication. Across these four therapeutic areas, Allucent also supports rare disease programs and cell and gene therapies, bringing additional expertise to their specialized recruitment, study design, and operational requirements.
Allucent is purpose-built to address the distinct scientific, regulatory, and operational needs of small and mid-size biopharma companies. Its high-touch, collaborative partnership model combines specialized expertise with flexible, integrated services. Allucent works as an extension of sponsors’ teams, providing the expertise and hands-on support needed to reach key milestones.
Allucent brings together global clinical development expertise and regional regulatory and operational knowledge to support multinational clinical trials. With the ability to conduct trials in more than 80 countries, Allucent supports activities ranging from site feasibility and study start-up to patient recruitment and retention, clinical operations, and regulatory support, helping sponsors coordinate trial activities across regions.
Allucent is built around a hands-on partnership model designed specifically for the needs of small and mid-size biopharma. Its integrated A-Team of former regulators, leading scientists, and senior clinical experts brings together scientific and operational expertise to help sponsors anticipate challenges and connect development strategies with trial execution. Its four Allucent Centers of Expertise (ACEs) add focused therapeutic knowledge to guide disease-specific development strategies, study design, and execution. Working as an extension of sponsors’ teams, Allucent provides collaborative support tailored to each program’s goals and key milestones.